Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
Insmed’s Return On Capital Employed Overview
According to data from Benzinga Pro, during Q1, Insmed's (NASDAQ:INSM) reported sales totaled $53.11 million. Despite a 16.25% increase in earnings, the company posted a loss of $94.62 million.
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Goldman Sachs Initiates Coverage On Insmed with Buy Rating, Announces Price Target of $56
Goldman Sachs analyst Andrea Tan initiates coverage on Insmed (NASDAQ:INSM) with a Buy rating and announces Price Target of $56.
Insmed’s Return On Capital Employed Insights
Insmed (NASDAQ:INSM) brought in sales totaling $56.12 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 0.23%, resulting in a loss of $112.98 million.
Earnings Scheduled For February 17, 2022
Companies Reporting Before The Bell
• Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate proceedings, and the week also witnessed presentations at conferences and a couple of initial public offerings.
JP Morgan Initiates Coverage On Insmed with Overweight Rating, Announces Price Target of $45
JP Morgan initiates coverage on Insmed (NASDAQ:INSM) with a Overweight rating and announces Price Target of $45.